Clinical Trials
16 trialsNCT01428973 2024-05-09
Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens
University of Liege
Phase 2 Unknown
NCT06279585 2024-02-28
Physical Therapy in Patients Undergoing Allo-HSCT With cGVHD
University of Seville
Phase NA Unknown
NCT05005299 2023-08-01
VICTORY
Melbourne Health
Phase 1 Unknown
NCT04688021 2023-02-21
A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.
First Affiliated Hospital of Zhejiang University
Phase 2 Unknown
NCT04033627 2022-09-29
TCDαβ/CD45RA Haploidentical Transplantation in Children With Leukemia
Shanghai Children's Medical Center
Phase NA Unknown
NCT05158608 2022-01-11
CY25
National Research Center for Hematology, Russia
Phase 3 Unknown
NCT04622956 2021-09-14
GVHD Prophylaxis With Methotrexate in Haploidentical HCT Using Posttransplant Cyclophosphamide
University of Sao Paulo General Hospital
Phase 1/2 Unknown
NCT03836690 2019-10-25
ToTem
University College, London
Phase 1 Unknown
NCT01240525 2019-02-12
ProT4
University College, London
Phase 2 Unknown
NCT02185261 2018-06-07
Interferon α for the Therapy of Minimal Residual Disease
Peking University People's Hospital
Phase NA Unknown
NCT03148197 2017-07-19
COLLECT
University of Cologne
Unknown
NCT00524784 2015-06-11
Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHD
Hadassah Medical Organization
Phase 1/2 Unknown
NCT00679536 2014-01-23
Allogeneic Transplantation for Pediatric Leukemias With Unrelated Donors
Ann & Robert H Lurie Children's Hospital of Chicago
Phase 1/2 Unknown
NCT00093587 2013-11-06
Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
National Cancer Institute (NCI)
Phase NA Unknown
NCT00462657 2013-08-26
Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease
National Cancer Institute (NCI)
Phase NA Unknown
NCT00740467 2010-01-28
Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders
National Cancer Institute (NCI)
Phase 2 Unknown